A 64-year-old with advanced prostate cancer underwent robotic surgery after hormonal therapy, achieving successful tumour ...

The prostate is a gland found in biological males, roughly the size of a walnut. It sits just below the bladder and in front ...

But what makes Tewari compelling is not just the scale of his achievement. It is the moral clarity with which he speaks about ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL ...

Transdermal estradiol patches and LHRH agonists led to similar metastasis-free and overall survival in locally advanced prostate cancer. Estradiol was associated with substantially lower incidence of ...

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...

Like most diseases, prostate cancer is most treatable and curable when caught early. Now, there's new hope for men diagnosed in the advanced stages of the disease. Immunotherapy has become the buzz ...

Androgen receptor-targeted agents (ARTAs) and docetaxel are cornerstone first-line treatments for advanced prostate cancer. However, within the post-ARTA, post-docetaxel metastatic ...

Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments have been game-changers for lung cancer and skin cancer, prostate cancer ...

Prostate cancer is the most common cancer in American men, with an estimated 333,830 new cases and 36,320 deaths projected for 2026 for the disease, according to the American Cancer Society. In the ...